nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—ovarian cancer	0.646	1	CbGaD
Meprobamate—ABCB1—Topotecan—ovarian cancer	0.0382	0.354	CbGbCtD
Meprobamate—ABCB1—Vinorelbine—ovarian cancer	0.0269	0.25	CbGbCtD
Meprobamate—ABCB1—Paclitaxel—ovarian cancer	0.0189	0.175	CbGbCtD
Meprobamate—ABCB1—Docetaxel—ovarian cancer	0.0137	0.127	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—ovarian cancer	0.0102	0.0945	CbGbCtD
Meprobamate—Ataxia—Altretamine—ovarian cancer	0.00767	0.0311	CcSEcCtD
Meprobamate—Hypotensive—Paclitaxel—ovarian cancer	0.00561	0.0228	CcSEcCtD
Meprobamate—Hyperpyrexia—Paclitaxel—ovarian cancer	0.00549	0.0223	CcSEcCtD
Meprobamate—Proctitis—Epirubicin—ovarian cancer	0.00479	0.0194	CcSEcCtD
Meprobamate—Proctitis—Doxorubicin—ovarian cancer	0.00443	0.018	CcSEcCtD
Meprobamate—Vertigo—Altretamine—ovarian cancer	0.00441	0.0179	CcSEcCtD
Meprobamate—Leukopenia—Altretamine—ovarian cancer	0.0044	0.0179	CcSEcCtD
Meprobamate—Lymphadenopathy—Chlorambucil—ovarian cancer	0.0034	0.0138	CcSEcCtD
Meprobamate—Anuria—Epirubicin—ovarian cancer	0.00335	0.0136	CcSEcCtD
Meprobamate—Rash maculo-papular—Topotecan—ovarian cancer	0.00323	0.0131	CcSEcCtD
Meprobamate—Anuria—Doxorubicin—ovarian cancer	0.0031	0.0126	CcSEcCtD
Meprobamate—Asthenia—Altretamine—ovarian cancer	0.00288	0.0117	CcSEcCtD
Meprobamate—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00286	0.0116	CcSEcCtD
Meprobamate—Ataxia—Chlorambucil—ovarian cancer	0.00273	0.0111	CcSEcCtD
Meprobamate—Dermatitis bullous—Topotecan—ovarian cancer	0.0027	0.011	CcSEcCtD
Meprobamate—Dizziness—Altretamine—ovarian cancer	0.00265	0.0108	CcSEcCtD
Meprobamate—Vomiting—Altretamine—ovarian cancer	0.00255	0.0103	CcSEcCtD
Meprobamate—Nausea—Altretamine—ovarian cancer	0.00238	0.00967	CcSEcCtD
Meprobamate—Dermatitis bullous—Vinorelbine—ovarian cancer	0.00231	0.00938	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00221	0.00899	CcSEcCtD
Meprobamate—Body temperature increased—Carboplatin—ovarian cancer	0.00219	0.00889	CcSEcCtD
Meprobamate—Stomatitis—Chlorambucil—ovarian cancer	0.00218	0.00884	CcSEcCtD
Meprobamate—Bronchospasm—Melphalan—ovarian cancer	0.00215	0.00872	CcSEcCtD
Meprobamate—Stomatitis—Topotecan—ovarian cancer	0.00194	0.00787	CcSEcCtD
Meprobamate—Stomatitis—Melphalan—ovarian cancer	0.0019	0.00771	CcSEcCtD
Meprobamate—Erythema multiforme—Chlorambucil—ovarian cancer	0.0019	0.0077	CcSEcCtD
Meprobamate—Oliguria—Docetaxel—ovarian cancer	0.00188	0.00764	CcSEcCtD
Meprobamate—Bronchospasm—Vinorelbine—ovarian cancer	0.00188	0.00762	CcSEcCtD
Meprobamate—Rash maculo-papular—Paclitaxel—ovarian cancer	0.00186	0.00755	CcSEcCtD
Meprobamate—Stomatitis—Vinorelbine—ovarian cancer	0.00166	0.00673	CcSEcCtD
Meprobamate—Agitation—Chlorambucil—ovarian cancer	0.0016	0.00651	CcSEcCtD
Meprobamate—Chills—Topotecan—ovarian cancer	0.0016	0.0065	CcSEcCtD
Meprobamate—Angioedema—Chlorambucil—ovarian cancer	0.0016	0.00648	CcSEcCtD
Meprobamate—Agranulocytosis—Vinorelbine—ovarian cancer	0.00159	0.00645	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00157	0.00639	CcSEcCtD
Meprobamate—Leukopenia—Chlorambucil—ovarian cancer	0.00156	0.00635	CcSEcCtD
Meprobamate—Arrhythmia—Melphalan—ovarian cancer	0.00156	0.00634	CcSEcCtD
Meprobamate—Petechiae—Epirubicin—ovarian cancer	0.00142	0.00577	CcSEcCtD
Meprobamate—Angioedema—Topotecan—ovarian cancer	0.00142	0.00577	CcSEcCtD
Meprobamate—Ataxia—Paclitaxel—ovarian cancer	0.0014	0.00567	CcSEcCtD
Meprobamate—Leukopenia—Topotecan—ovarian cancer	0.00139	0.00565	CcSEcCtD
Meprobamate—Arrhythmia—Vinorelbine—ovarian cancer	0.00136	0.00554	CcSEcCtD
Meprobamate—Leukopenia—Melphalan—ovarian cancer	0.00136	0.00553	CcSEcCtD
Meprobamate—Dermatitis bullous—Docetaxel—ovarian cancer	0.00132	0.00535	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—ovarian cancer	0.00132	0.00534	CcSEcCtD
Meprobamate—Oliguria—Epirubicin—ovarian cancer	0.00127	0.00515	CcSEcCtD
Meprobamate—Anaphylactic shock—Topotecan—ovarian cancer	0.00127	0.00515	CcSEcCtD
Meprobamate—Anaphylactic shock—Melphalan—ovarian cancer	0.00124	0.00504	CcSEcCtD
Meprobamate—Dysarthria—Epirubicin—ovarian cancer	0.00124	0.00502	CcSEcCtD
Meprobamate—Angioedema—Vinorelbine—ovarian cancer	0.00121	0.00493	CcSEcCtD
Meprobamate—Tachycardia—Melphalan—ovarian cancer	0.00121	0.00492	CcSEcCtD
Meprobamate—Vertigo—Vinorelbine—ovarian cancer	0.00119	0.00485	CcSEcCtD
Meprobamate—Leukopenia—Vinorelbine—ovarian cancer	0.00119	0.00483	CcSEcCtD
Meprobamate—Ataxia—Docetaxel—ovarian cancer	0.00118	0.00481	CcSEcCtD
Meprobamate—Palpitations—Vinorelbine—ovarian cancer	0.00117	0.00477	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—ovarian cancer	0.00117	0.00477	CcSEcCtD
Meprobamate—Hypotension—Melphalan—ovarian cancer	0.00116	0.00471	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—ovarian cancer	0.00114	0.00465	CcSEcCtD
Meprobamate—Paraesthesia—Topotecan—ovarian cancer	0.00114	0.00462	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00113	0.00461	CcSEcCtD
Meprobamate—Body temperature increased—Chlorambucil—ovarian cancer	0.00113	0.00457	CcSEcCtD
Meprobamate—Stomatitis—Paclitaxel—ovarian cancer	0.00112	0.00453	CcSEcCtD
Meprobamate—Paraesthesia—Melphalan—ovarian cancer	0.00112	0.00453	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—ovarian cancer	0.0011	0.00446	CcSEcCtD
Meprobamate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00109	0.00441	CcSEcCtD
Meprobamate—Bronchospasm—Docetaxel—ovarian cancer	0.00107	0.00434	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—ovarian cancer	0.00106	0.00432	CcSEcCtD
Meprobamate—Tachycardia—Vinorelbine—ovarian cancer	0.00106	0.0043	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—ovarian cancer	0.00106	0.00429	CcSEcCtD
Meprobamate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00105	0.00426	CcSEcCtD
Meprobamate—Asthenia—Chlorambucil—ovarian cancer	0.00102	0.00415	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00102	0.00413	CcSEcCtD
Meprobamate—Hypotension—Vinorelbine—ovarian cancer	0.00101	0.00412	CcSEcCtD
Meprobamate—Oedema peripheral—Paclitaxel—ovarian cancer	0.00101	0.00411	CcSEcCtD
Meprobamate—Pruritus—Chlorambucil—ovarian cancer	0.00101	0.00409	CcSEcCtD
Meprobamate—Body temperature increased—Topotecan—ovarian cancer	0.001	0.00407	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—ovarian cancer	0.000995	0.00404	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—ovarian cancer	0.000984	0.00399	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—ovarian cancer	0.000978	0.00397	CcSEcCtD
Meprobamate—Diarrhoea—Chlorambucil—ovarian cancer	0.000975	0.00396	CcSEcCtD
Meprobamate—Paraesthesia—Vinorelbine—ovarian cancer	0.000974	0.00396	CcSEcCtD
Meprobamate—Erythema multiforme—Paclitaxel—ovarian cancer	0.000971	0.00394	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000962	0.0039	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—ovarian cancer	0.000949	0.00385	CcSEcCtD
Meprobamate—Stomatitis—Docetaxel—ovarian cancer	0.000945	0.00384	CcSEcCtD
Meprobamate—Hypersensitivity—Topotecan—ovarian cancer	0.000935	0.00379	CcSEcCtD
Meprobamate—Chills—Paclitaxel—ovarian cancer	0.000922	0.00374	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—ovarian cancer	0.000921	0.00374	CcSEcCtD
Meprobamate—Arrhythmia—Paclitaxel—ovarian cancer	0.000918	0.00373	CcSEcCtD
Meprobamate—Hypersensitivity—Melphalan—ovarian cancer	0.000915	0.00372	CcSEcCtD
Meprobamate—Asthenia—Topotecan—ovarian cancer	0.00091	0.0037	CcSEcCtD
Meprobamate—Vomiting—Chlorambucil—ovarian cancer	0.000906	0.00368	CcSEcCtD
Meprobamate—Agranulocytosis—Docetaxel—ovarian cancer	0.000905	0.00368	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.0009	0.00365	CcSEcCtD
Meprobamate—Pruritus—Topotecan—ovarian cancer	0.000897	0.00364	CcSEcCtD
Meprobamate—Asthenia—Melphalan—ovarian cancer	0.000891	0.00362	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—ovarian cancer	0.000888	0.00361	CcSEcCtD
Meprobamate—Purpura—Epirubicin—ovarian cancer	0.000881	0.00358	CcSEcCtD
Meprobamate—Pruritus—Melphalan—ovarian cancer	0.000879	0.00357	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—ovarian cancer	0.000878	0.00357	CcSEcCtD
Meprobamate—Diarrhoea—Topotecan—ovarian cancer	0.000868	0.00352	CcSEcCtD
Meprobamate—Body temperature increased—Vinorelbine—ovarian cancer	0.000858	0.00348	CcSEcCtD
Meprobamate—Oedema peripheral—Docetaxel—ovarian cancer	0.000858	0.00348	CcSEcCtD
Meprobamate—Diarrhoea—Melphalan—ovarian cancer	0.00085	0.00345	CcSEcCtD
Meprobamate—Nausea—Chlorambucil—ovarian cancer	0.000846	0.00344	CcSEcCtD
Meprobamate—Dizziness—Topotecan—ovarian cancer	0.000839	0.00341	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000832	0.00338	CcSEcCtD
Meprobamate—Erythema multiforme—Docetaxel—ovarian cancer	0.000823	0.00334	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000822	0.00334	CcSEcCtD
Meprobamate—Agitation—Paclitaxel—ovarian cancer	0.000822	0.00334	CcSEcCtD
Meprobamate—Angioedema—Paclitaxel—ovarian cancer	0.000817	0.00332	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—ovarian cancer	0.000815	0.00331	CcSEcCtD
Meprobamate—Vomiting—Topotecan—ovarian cancer	0.000806	0.00327	CcSEcCtD
Meprobamate—Vertigo—Paclitaxel—ovarian cancer	0.000803	0.00326	CcSEcCtD
Meprobamate—Syncope—Paclitaxel—ovarian cancer	0.000802	0.00326	CcSEcCtD
Meprobamate—Leukopenia—Paclitaxel—ovarian cancer	0.0008	0.00325	CcSEcCtD
Meprobamate—Hypersensitivity—Vinorelbine—ovarian cancer	0.000799	0.00325	CcSEcCtD
Meprobamate—Dermatitis—Topotecan—ovarian cancer	0.000799	0.00324	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—ovarian cancer	0.000798	0.00324	CcSEcCtD
Meprobamate—Headache—Topotecan—ovarian cancer	0.000795	0.00323	CcSEcCtD
Meprobamate—Palpitations—Paclitaxel—ovarian cancer	0.00079	0.00321	CcSEcCtD
Meprobamate—Vomiting—Melphalan—ovarian cancer	0.00079	0.00321	CcSEcCtD
Meprobamate—Loss of consciousness—Paclitaxel—ovarian cancer	0.000786	0.00319	CcSEcCtD
Meprobamate—Dermatitis—Melphalan—ovarian cancer	0.000782	0.00318	CcSEcCtD
Meprobamate—Chills—Docetaxel—ovarian cancer	0.000781	0.00317	CcSEcCtD
Meprobamate—Asthenia—Vinorelbine—ovarian cancer	0.000779	0.00316	CcSEcCtD
Meprobamate—Arrhythmia—Docetaxel—ovarian cancer	0.000778	0.00316	CcSEcCtD
Meprobamate—Pruritus—Vinorelbine—ovarian cancer	0.000768	0.00312	CcSEcCtD
Meprobamate—Nausea—Topotecan—ovarian cancer	0.000753	0.00306	CcSEcCtD
Meprobamate—Diarrhoea—Vinorelbine—ovarian cancer	0.000742	0.00301	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—ovarian cancer	0.000739	0.003	CcSEcCtD
Meprobamate—Nausea—Melphalan—ovarian cancer	0.000738	0.003	CcSEcCtD
Meprobamate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00073	0.00296	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—ovarian cancer	0.000726	0.00295	CcSEcCtD
Meprobamate—Shock—Paclitaxel—ovarian cancer	0.000718	0.00292	CcSEcCtD
Meprobamate—Dizziness—Vinorelbine—ovarian cancer	0.000718	0.00291	CcSEcCtD
Meprobamate—Tachycardia—Paclitaxel—ovarian cancer	0.000712	0.00289	CcSEcCtD
Meprobamate—Vomiting—Vinorelbine—ovarian cancer	0.00069	0.0028	CcSEcCtD
Meprobamate—Dermatitis—Vinorelbine—ovarian cancer	0.000684	0.00278	CcSEcCtD
Meprobamate—Hypotension—Paclitaxel—ovarian cancer	0.000682	0.00277	CcSEcCtD
Meprobamate—Headache—Vinorelbine—ovarian cancer	0.00068	0.00276	CcSEcCtD
Meprobamate—Syncope—Docetaxel—ovarian cancer	0.00068	0.00276	CcSEcCtD
Meprobamate—Leukopenia—Docetaxel—ovarian cancer	0.000678	0.00275	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—ovarian cancer	0.000672	0.00273	CcSEcCtD
Meprobamate—Palpitations—Docetaxel—ovarian cancer	0.00067	0.00272	CcSEcCtD
Meprobamate—Loss of consciousness—Docetaxel—ovarian cancer	0.000666	0.0027	CcSEcCtD
Meprobamate—Paraesthesia—Paclitaxel—ovarian cancer	0.000655	0.00266	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—ovarian cancer	0.000654	0.00266	CcSEcCtD
Meprobamate—Somnolence—Paclitaxel—ovarian cancer	0.000649	0.00263	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000649	0.00263	CcSEcCtD
Meprobamate—Nausea—Vinorelbine—ovarian cancer	0.000645	0.00262	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—ovarian cancer	0.000638	0.00259	CcSEcCtD
Meprobamate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000619	0.00251	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—ovarian cancer	0.000611	0.00248	CcSEcCtD
Meprobamate—Shock—Docetaxel—ovarian cancer	0.000609	0.00247	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—ovarian cancer	0.000605	0.00246	CcSEcCtD
Meprobamate—Tachycardia—Docetaxel—ovarian cancer	0.000604	0.00245	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.0006	0.00244	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—ovarian cancer	0.00059	0.0024	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—ovarian cancer	0.000579	0.00235	CcSEcCtD
Meprobamate—Hypotension—Docetaxel—ovarian cancer	0.000578	0.00235	CcSEcCtD
Meprobamate—Body temperature increased—Paclitaxel—ovarian cancer	0.000577	0.00234	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—ovarian cancer	0.000565	0.00229	CcSEcCtD
Meprobamate—Paraesthesia—Docetaxel—ovarian cancer	0.000555	0.00226	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—ovarian cancer	0.000555	0.00225	CcSEcCtD
Meprobamate—Somnolence—Docetaxel—ovarian cancer	0.00055	0.00223	CcSEcCtD
Meprobamate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000538	0.00218	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—ovarian cancer	0.000535	0.00217	CcSEcCtD
Meprobamate—Chills—Epirubicin—ovarian cancer	0.000527	0.00214	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—ovarian cancer	0.000525	0.00213	CcSEcCtD
Meprobamate—Asthenia—Paclitaxel—ovarian cancer	0.000524	0.00213	CcSEcCtD
Meprobamate—Pruritus—Paclitaxel—ovarian cancer	0.000516	0.0021	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—ovarian cancer	0.000514	0.00209	CcSEcCtD
Meprobamate—Diarrhoea—Paclitaxel—ovarian cancer	0.000499	0.00203	CcSEcCtD
Meprobamate—Body temperature increased—Docetaxel—ovarian cancer	0.000489	0.00199	CcSEcCtD
Meprobamate—Chills—Doxorubicin—ovarian cancer	0.000488	0.00198	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—ovarian cancer	0.000485	0.00197	CcSEcCtD
Meprobamate—Dizziness—Paclitaxel—ovarian cancer	0.000483	0.00196	CcSEcCtD
Meprobamate—Agitation—Epirubicin—ovarian cancer	0.00047	0.00191	CcSEcCtD
Meprobamate—Vomiting—Paclitaxel—ovarian cancer	0.000464	0.00188	CcSEcCtD
Meprobamate—Dermatitis—Paclitaxel—ovarian cancer	0.00046	0.00187	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—ovarian cancer	0.000459	0.00187	CcSEcCtD
Meprobamate—Syncope—Epirubicin—ovarian cancer	0.000458	0.00186	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—ovarian cancer	0.000458	0.00186	CcSEcCtD
Meprobamate—Headache—Paclitaxel—ovarian cancer	0.000457	0.00186	CcSEcCtD
Meprobamate—Hypersensitivity—Docetaxel—ovarian cancer	0.000456	0.00185	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—ovarian cancer	0.000452	0.00183	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—ovarian cancer	0.000449	0.00182	CcSEcCtD
Meprobamate—Asthenia—Docetaxel—ovarian cancer	0.000444	0.0018	CcSEcCtD
Meprobamate—Pruritus—Docetaxel—ovarian cancer	0.000438	0.00178	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—ovarian cancer	0.000435	0.00177	CcSEcCtD
Meprobamate—Nausea—Paclitaxel—ovarian cancer	0.000434	0.00176	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—ovarian cancer	0.000425	0.00173	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—ovarian cancer	0.000424	0.00172	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—ovarian cancer	0.000423	0.00172	CcSEcCtD
Meprobamate—Diarrhoea—Docetaxel—ovarian cancer	0.000423	0.00172	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—ovarian cancer	0.000418	0.0017	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000417	0.00169	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—ovarian cancer	0.000416	0.00169	CcSEcCtD
Meprobamate—Shock—Epirubicin—ovarian cancer	0.000411	0.00167	CcSEcCtD
Meprobamate—Dizziness—Docetaxel—ovarian cancer	0.000409	0.00166	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—ovarian cancer	0.000407	0.00165	CcSEcCtD
Meprobamate—Vomiting—Docetaxel—ovarian cancer	0.000393	0.0016	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—ovarian cancer	0.00039	0.00158	CcSEcCtD
Meprobamate—Dermatitis—Docetaxel—ovarian cancer	0.00039	0.00158	CcSEcCtD
Meprobamate—Headache—Docetaxel—ovarian cancer	0.000388	0.00157	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000386	0.00157	CcSEcCtD
Meprobamate—Shock—Doxorubicin—ovarian cancer	0.00038	0.00154	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—ovarian cancer	0.000377	0.00153	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—ovarian cancer	0.000375	0.00152	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—ovarian cancer	0.000371	0.00151	CcSEcCtD
Meprobamate—Nausea—Docetaxel—ovarian cancer	0.000367	0.00149	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—ovarian cancer	0.000361	0.00146	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—ovarian cancer	0.000347	0.00141	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—ovarian cancer	0.000343	0.00139	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—ovarian cancer	0.00033	0.00134	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—ovarian cancer	0.000307	0.00125	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—ovarian cancer	0.000305	0.00124	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—ovarian cancer	0.000299	0.00122	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—ovarian cancer	0.000295	0.0012	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—ovarian cancer	0.000285	0.00116	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000284	0.00115	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—ovarian cancer	0.000277	0.00112	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—ovarian cancer	0.000276	0.00112	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—ovarian cancer	0.000273	0.00111	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—ovarian cancer	0.000265	0.00108	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—ovarian cancer	0.000264	0.00107	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—ovarian cancer	0.000263	0.00107	CcSEcCtD
Meprobamate—Headache—Epirubicin—ovarian cancer	0.000261	0.00106	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—ovarian cancer	0.000255	0.00104	CcSEcCtD
Meprobamate—Nausea—Epirubicin—ovarian cancer	0.000248	0.00101	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—ovarian cancer	0.000245	0.000997	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—ovarian cancer	0.000243	0.000987	CcSEcCtD
Meprobamate—Headache—Doxorubicin—ovarian cancer	0.000242	0.000982	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—ovarian cancer	0.000229	0.000931	CcSEcCtD
